GMAB logo

Genmab A/S (GMAB)

Profile

Full Name

Genmab A/S

Ticker Symbol

GMAB

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Denmark

IPO

June 1, 2009

Indexes

Not included

Website

http://www.genmab.com

Employees

2682

Key Details

Price

$19.39(+0.34%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$3.12B(+30.58% YoY)

Annual EPS

$1.76(+83.70% YoY)

PE ratio

11.07

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$19.39
GMAB price is $19.39

30-Day Relative Volume

1.27
GMAB 30-day relative volume is 1.27

Price Performance

Price Today change

+0.34%
GMAB price is up +0.34% today

Price YTD change

-7.12%
GMAB price is down -7.12% since January 1st

Price 1-year change

-34.31%
GMAB price is down -34.31% year-on-year

Price 3-year change

-47.25%
GMAB price is down -47.25% over the past 3 years

Price Range

Price All-time high

$103.19
GMAB price is currently -81.21% below its historical high of $103.19

Price 3-year low

$17.23
GMAB price is currently +12.47% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$12.32B
GMAB market capitalization is $12.32 billion

Market cap 3-year change

-49%
GMAB market capitalization is down -49% over the past 3 years

Market cap All-time high

$31.85B
GMAB market capitalization is currently -61.33% below its historical high of $31.85 billion

Market cap sector rank

94.16%
GMAB market capitalization is higher than 94.16% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-2.22%
GMAB shares outstanding is down -2.22% year-on-year

Shares Outstanding 3-Year Change

-3.32%
GMAB shares outstanding is down -3.32% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.51
GMAB beta is 0.51

200-day SMA

$23.06
GMAB price is currently -15.95% below its 200-day simple moving average

50-day SMA

$20.47
GMAB price is currently -5.30% below its 50-day simple moving average

RSI

48.13
GMAB 14-day relative strength index is 48.13

Volume

1.27
GMAB 30-day relative volume is 1.27

ATR

$0.72
GMAB average true range is $0.72

10-day Historical Volatility

57.52%
GMAB 10-day historical volatility is 57.52%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$3.12B
GMAB annual revenue is $3.12 billion

Revenue Analysts estimate

$24.69B
GMAB annual revenue is currently -87.35% lower than the consensus analysts' forecast

Revenue 1-year change

+30.58%
GMAB annual revenue is up +30.58% year-on-year

Revenue Sector rank

89.03%
GMAB annual revenue is higher than 89.03% of companies in Healthcare sector

EPS

EPS

$1.76
GMAB annual earnings per share is $1.76

EPS Analysts estimate

$1.38
GMAB annual earnings per share is currently +27.38% higher than the consensus analysts' forecast

EPS 1-year change

+83.7%
GMAB annual earnings per share is up +83.7% year-on-year

EPS Sector rank

91.73%
GMAB annual earnings per share is higher than 91.73% of companies in Healthcare sector

Profit

Gross profit

$2.98B
GMAB annual gross profit is $2.98 billion

Gross margin

95.42%
GMAB annual gross profit margin is 95.42%

Operating profit

$1.02B
GMAB annual operating income is $1.02 billion

Operating margin

32.53%
GMAB annual operating profit margin is 32.53%

Net income

$1.14B
GMAB annual net profit is $1.14 billion

Net margin

36.44%
GMAB annual net profit margin is 36.44%

Expenses

Total expenses

$2.11B
GMAB annual total expenses is $2.11 billion

Operating expenses

$1.96B
GMAB annual total operating expenses is $1.96 billion

Cost of goods sold

$142.91M
GMAB annual cost of goods sold is $142.91 million

Selling, general & administrative expenses

$549.89M
GMAB annual SGA is $549.89 million

Depreciation and amortization

$59.92M
GMAB annual depreciation & amortization is $59.92 million

Interest expense

$17.41M
GMAB annual interest expense is $17.41 million

Income tax

$191.52M
GMAB annual income tax is $191.52 million

EBIT & EBITDA

EBIT

$1.35B
GMAB annual earnings before interest & taxes is $1.35 billion

EBITDA

$1.41B
GMAB annual EBITDA is $1.41 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$6.39B
GMAB annual total assets is $6.39 billion

Non current assets

$2.51B
GMAB annual long term assets is $2.51 billion

Current assets

$3.89B
GMAB annual total current assets is $3.89 billion

Cash and cash equivalents

$1.38B
GMAB annual cash & cash equivalents is $1.38 billion

Accounts receivable

$919.42M
GMAB annual accounts receivable is $919.42 million

Inventory

$8.65M
GMAB annual inventory is $8.65 million

Liabilities

Total liabilities

$1.27B
GMAB annual total liabilities is $1.27 billion

Long term liabilities

$531.00M
GMAB annual total long term liabilities is $531.00 million

Current liabilities

$740.56M
GMAB annual total current liabilities is $740.56 million

Accounts payable

-
GMAB annual accounts payable value is unknown

Debt

Total debt

$143.56M
GMAB annual total debt is $143.56 million

Total debt 1-year change

+25.58%
GMAB annual total debt is up +25.58% year-on-year

Long term debt

$130.73M
GMAB annual long term debt is $130.73 million

Short term debt

$12.84M
GMAB annual short term debt is $12.84 million

Equity & Capital

Shareholders equity

$5.12B
GMAB annual stockholders equity is $5.12 billion

Book value

$5.12B
GMAB annual book value is $5.12 billion

Retained earnings

$3.29B
GMAB annual retained earnings is $3.29 billion

Working capital

$3.15B
GMAB annual working capital is $3.15 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$1.13B
GMAB annual cash flow from operations is $1.13 billion

Cash from operations 1-year change

+5.23%
GMAB annual cash flow from operations is up +5.23% year-on-year

Cash from investing

-$1.44B
GMAB annual cash flow from investing activities is -$1.44 billion

Cash from investing 1-year change

-672.26%
GMAB annual cash flow from investing activities is down -672.26% year-on-year

Cash from financing

-$568.60M
GMAB annual cash flow from financing activities is -$568.60 million

Cash from financing 1-year change

-546.27%
GMAB annual cash flow from financing activities is down -546.27% year-on-year

CAPEX

CAPEX

$44.11M
GMAB annual capital expenditures is $44.11 million

CAPEX 1-year change

-19.2%
GMAB annual capital expenditures is down -19.2% year-on-year

Free Cash Flow

Free cash flow

$1.08B
GMAB annual free cash flow is $1.08 billion

Free cash flow 1-year change

+6.54%
GMAB annual free cash flow is up +6.54% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

95.42%
GMAB annual gross profit margin is 95.42%

Operating margin

32.53%
GMAB annual operating profit margin is 32.53%

Net margin

36.44%
GMAB annual net profit margin is 36.44%

ROA & ROE

ROA

19.57%
GMAB annual return on assets is 19.57%

ROE

23.20%
GMAB annual return on equity is 23.20%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

11.07
GMAB price to earnings ratio is 11.07

PE ratio Sector rank

17.65%
GMAB price to earnings ratio is higher than 17.65% of companies in Healthcare sector

PB Ratio

PB ratio

2.41
GMAB price to book ratio is 2.41

PB ratio Sector rank

67.82%
GMAB price to book ratio is higher than 67.82% of companies in Healthcare sector

PS Ratio

PS ratio

3.95
GMAB price to sales ratio is 3.95

PS ratio Sector rank

60.64%
GMAB price to sales ratio is higher than 60.64% of companies in Healthcare sector

Enterprise value

Enterprise value

$11.09B
GMAB enterprise value is $11.09 billion

Enterprise value Sector rank

92.73%
GMAB enterprise value is higher than 92.73% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

8.08
GMAB EV/EBITDA is 8.08

EV/EBITDA Sector rank

80.78%
GMAB EV/EBITDA is higher than 80.78% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

5.25
GMAB annual current ratio is 5.25

Quick ratio

5.24
GMAB annual quick ratio is 5.24

Leverage

Debt to equity

0.00
GMAB annual debt to equity ratio is 0.00

Interest coverage ratio

77.37
GMAB annual interest coverage ratio is 77.37

Risk & Stability

Piotroski F-Score

5
GMAB piotroski f-score is 5

Altman Z-Score

8.31
GMAB altman z-score is 8.31

Analyst ratings

Recent major analysts updates

Apr 9, 25 HC Wainwright & Co.
Buy
Mar 11, 25 William Blair
Outperform
Mar 11, 25 Truist Securities
Buy
Feb 13, 25 Leerink Partners
Outperform
Jan 23, 25 HC Wainwright & Co.
Buy
Jan 22, 25 HC Wainwright & Co.
Buy
Jan 8, 25 HC Wainwright & Co.
Buy
Nov 8, 24 BMO Capital
Outperform
Oct 16, 24 HC Wainwright & Co.
Buy
Sep 20, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

ALGN logo
Align Technology (ALGN)
DVA logo
DaVita (DVA)
COR logo
Cencora (COR)
ILMN logo
Illumina (ILMN)
THC logo
Tenet Healthcare (THC)
ICLR logo
ICON Public Limited (ICLR)
UTHR logo
United Therapeutics (UTHR)
RVTY logo
Revvity (RVTY)
SOLV logo
Solventum (SOLV)
  • What is the ticker symbol for Genmab A/S?
  • Does Genmab A/S pay dividends?
  • What sector is Genmab A/S in?
  • What industry is Genmab A/S in?
  • What country is Genmab A/S based in?
  • When did Genmab A/S go public?
  • Is Genmab A/S in the S&P 500?
  • Is Genmab A/S in the NASDAQ 100?
  • Is Genmab A/S in the Dow Jones?
  • When was Genmab A/S's last earnings report?
  • When does Genmab A/S report earnings?

What is the ticker symbol for Genmab A/S?

The ticker symbol for Genmab A/S is NASDAQ:GMAB

Does Genmab A/S pay dividends?

No, Genmab A/S does not pay dividends

What sector is Genmab A/S in?

Genmab A/S is in the Healthcare sector

What industry is Genmab A/S in?

Genmab A/S is in the Biotechnology industry

What country is Genmab A/S based in?

Genmab A/S is headquartered in Denmark

When did Genmab A/S go public?

Genmab A/S's initial public offering (IPO) was on June 1, 2009

Is Genmab A/S in the S&P 500?

No, Genmab A/S is not included in the S&P 500 index

Is Genmab A/S in the NASDAQ 100?

No, Genmab A/S is not included in the NASDAQ 100 index

Is Genmab A/S in the Dow Jones?

No, Genmab A/S is not included in the Dow Jones index

When was Genmab A/S's last earnings report?

Genmab A/S's most recent earnings report was on Feb 12, 2025

When does Genmab A/S report earnings?

The next expected earnings date for Genmab A/S is May 8, 2025
On this page